Technology Transfer Without Friction
Moving a manufacturing process into a new facility is one of the highest-stakes activities in drug development. BioCina's structured, fully documented methodology ensures your process arrives ready to run, to specification, and to regulatory standard.
Transfers That Hold Up to Scrutiny
Structured Transfer Protocol
Every transfer follows a defined protocol with formal gap analysis, shared accountability, and data-driven decision making at every stage. Scope, responsibilities, and acceptance criteria confirmed before execution begins.
Analytical Method Transfer
Analytical methods formally verified to USP 1224 and Ph. Eur. 5.8 standards, with re-validation completed where required before first GMP batch release.
Process Comparability Package
Demonstration batches at BioCina's scale confirm process performance, generating comparability data supporting IND, CTA, and commercial site transfer submissions.
CMC Filing Support
Formal comparability report and CMC authoring support for regulatory submissions throughout and beyond the transfer program.
Structured Assessment Before Execution
Single Accountable Partner
For programs transferring both drug substance and drug product, one manufacturing partner manages the full transfer scope with one project management interface, eliminating the inter-site comparability requirement at the DS-to-DP handover.
Start Your Transfer Assessment
Connect with our experts to discuss your technology transfer requirements and how BioCina can move your program forward without losing momentum.